Abstract:Tumor angiogenesis is characterized by abnormal vessel morphology leading to erratic and insufficient delivery of chemotherapeutics and oxygen, making the tumor core not only highly hypoxic but also unresponsive toward treatment. Such hypoxic conditions promote tumor aggressiveness, leading to the establishment of metastatic disease. Most anti-angiogenic treatments aim toward the destruction of tumor vasculature, which proves countereffective by further increasing its aggressive nature. Hence, developing drugs which target or regulate these processes might lead to a better delivery of chemotherapeutics resulting in tumor shrinkage. Plant-derived natural compounds having a bioactive ingredient, especially triterpenoids, have been known to possess anticancer properties. AECHL-1, a recently isolated novel triterpenoid with proven anticancer potential, is seemingly noncytotoxic toward HEK 293 and HUVECs. Also, cytotoxicity was absent during in vivo studies involving intraperitoneal injections with 5 µg/kg body weight AECHL-1 on SCID mice. When used at subtoxic doses, it was found to be effective in suppression of neo-vessel formation as demonstrated in the chick chorioallantoic membrane, rat aortic rings, Matrigel plugs and xenograft tumors implanted in SCID mice. Tumor vasculature from AECHL-1-treated mice showed greater mural cell coverage and relatively normalized architecture. Investigations into the molecular mechanisms responsible for these observations revealed an effect on the actin cytoskeleton of stimulated HUVECs as well as the VEGFR2-mediated MAPK pathway. AECHL-1 could effectively distinguish between stimulated and nonstimulated endothelial cells. AECHL-1 could also downregulate HIF-1α expression and VEGF secretion under hypoxic conditions, thus reducing the fears of unnecessarily aggravating tumor metastasis as a result of anti-angiogenic therapy. Results obtained from the aforementioned studies make it clear that though AECHL-1 shows promise in discouraging and pruning neo-vasculature, it may not affect existing vasculature as the doses used for the assays are significantly lower than the ones causing endothelial cell death and has potential to be considered as a candidate for therapeutic drug development.

CHM-1, a New Vascular Targeting Agent, Induces Apoptosis of Human Umbilical Vein Endothelial Cells Via P53-Mediated Death Receptor 5 Up-regulation

CHM-1 Induces Apoptosis Via P38-Mediated Upregulation of DR5 Expression in Human Ovarian Cancer SKOV3 Cells

Chm-1, A Novel Synthetic Quinolone with Potent and Selective Antimitotic Antitumor Activity Against Human Hepatocellular Carcinoma in Vitro and in Vivo

Quinazoline Analog HMJ-30 Inhibits Angiogenesis: Involvement of Endothelial Cell Apoptosis Through ROS-JNK-mediated Death Receptor 5 Signaling.

Newly synthesized quinazolinone HMJ-38 suppresses angiogenetic responses and triggers human umbilical vein endothelial cell apoptosis through p53-modulated Fas/death receptor signaling.

The Synthesized 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1) Promoted G2/M Arrest Through Inhibition of CDK1 and Induced Apoptosis Through the Mitochondrial-Dependent Pathway in CT-26 Murine Colorectal Adenocarcinoma Cells

CHM-1, a Novel Microtubule-Destabilizing Agent Exhibits Antitumor Activity Via Inducing the Expression of SIRT2 in Human Breast Cancer Cells.

Chm-1 Inhibits Hepatocyte Growth Factor-Induced Invasion of Sk-Hep-1 Human Hepatocellular Carcinoma Cells by Suppressing Matrix Metalloproteinase-9 Expression

The Role of the Hepatocyte Growth Factor/c-Met Pathway in Pancreatic Stellate Cell-Endothelial Cell Interactions: Anti-angiogenic Implications in Pancreatic Cancer

Novel Complex of Copper and a Salicylaldehyde Pyrazole Hydrazone Derivative Induces Apoptosis through Up-Regulating Integrin β4 in Vascular Endothelial Cells

A Natural Small Molecule Harmine Inhibits Angiogenesis and Suppresses Tumour Growth Through Activation of P53 in Endothelial Cells

Novel Complex Of Copper And A Salicylaldehyde Pyrazole Hydrazone Derivative Induces Apoptosis Through Up-Regulating Integrin Beta 4 In Vascular Endothelial Cells

Inhibition of the Insulin-Like Growth Factor 1 Receptor by CHM-1 Blocks Proliferation of Glioblastoma Multiforme Cells.

Critical role of heme oxygenase-1 in chaetoglobosin A by triggering reactive oxygen species mediated mitochondrial apoptosis in colorectal Cancer

Directional Modification of Chrysin for Exerting Apoptosis and Enhancing Significantly Anti-Cancer Effects of 10-Hydroxy Camptothecin.

DHMMF, a natural flavonoid from Resina Draconis , inhibits hepatocellular carcinoma progression via inducing apoptosis and G2/M phase arrest mediated by DNA damage-driven upregulation of p21

16-O-caffeoyl-16-hydroxylhexadecanoic Acid, a Medicinal Plant-Derived Phenylpropanoid, Induces Apoptosis in Human Hepatocarcinoma Cells Through ROS-dependent Endoplasmic Reticulum Stress.

Novel Chalcone Derivatives As Hypoxia-Inducible Factor (HIF)-1 Inhibitor: Synthesis, Anti-Invasive and Anti-Angiogenic Properties

AECHL-1, a novel triterpenoid, targets tumor neo-vasculature and impairs the endothelial cell cytoskeleton

Low-concentration HCP1 Inhibits Apoptosis in Vascular Endothelial Cells.

Novel Quinolone Chm-1 Induces Apoptosis and Inhibits Metastasis in A Human Osterogenic Sarcoma Cell Line